Aging of the brain is characterized by deleterious processes at various levels including cellular/molecular and ...

Lu]Lu-PSMA-617 radiopharmaceutical therapy has been approved for the treatment of men with metastatic castration-resistant ...

Prostate-specific membrane antigen (PSMA) is a promising target in prostate cancer. Recently, we started the first-in-human treatment with an α-radionuclide–labeled PSMA ligand. Although the case ...

Journal of Nuclear Medicine August 2025, jnumed.125.270317; DOI: https://doi.org/10.2967/jnumed.125.270317 ...

Journal of Nuclear Medicine September 2025, jnumed.125.270267; DOI: https://doi.org/10.2967/jnumed.125.270267 ...

Several neurodegenerative disorders exhibit pathologic aggregation of the tau protein in the brain and are therefore summarized under the term tauopathies ( [1] [1]). Alzheimer disease (AD) is ...

Primary sclerosing cholangitis (PSC) is a chronic cholestatic disease marked by fibrosis, strictures, and a high risk for developing cholangiocarcinoma (CCC). Recognition of CCC in PSC remains a ...

Journal of Nuclear Medicine October 2025, jnumed.124.269188; DOI: https://doi.org/10.2967/jnumed.124.269188 ...

Sarcoidosis is a systemic granulomatous disease of unknown etiology. Cardiac involvement may occur, leading to an adverse outcome. Although early treatment to improve morbidity and mortality is ...

Bronchioloalveolar carcinoma (BAC) is a peripheral, well-differentiated neoplasm typically arising beyond a recognizable bronchus. It has a tendency to spread to the peripheral air spaces using the ...

Advances in multidetector CT (MDCT) technology with submillimeter slice collimation and high temporal resolution permit contrast-enhanced imaging of coronary arteries and coronary plaque during a ...

PET/CT using 18 F-FDG plays a critical role in oncology and hematology as a diagnostic, prognostic, and predictive tool (1). Moreover, 18 F-FDG PET/CT is used to assess response to treatment.